| Symbol | AKAN |
|---|---|
| Name | AKANDA CORP. |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | 1A, 1B LEAROYD ROAD, NEW ROMNEY, TN28 8XU, United Kingdom |
| Telephone | +44 2034889514 |
| Fax | — |
| — | |
| Website | https://www.akandacorp.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Akanda Corp is an international medical cannabis company cultivating cannabis of the highest quality at scale, leveraging trusted brands, at a low-cost compared to many of its competitors. The company is building a seed-to-patient supply chain, connecting patients in the UK and Europe with diverse products including cannabis products cultivated at its competitively advantaged grow operation in the Kingdom of Lesotho and with other trusted third-party brands. Additional info from NASDAQ: |
New Form F-1/A - AKANDA CORP. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001213900-26-008630 <b>Size:</b> 200 KB
Read moreHRT FINANCIAL LP 🟡 adjusted position in 21.2K shares of AKANDA CORP. (AKAN) at $1.40 Transaction Date: Jan 15, 2025 | Filing ID: 000002
Read moreNew Form 3 - AKANDA CORP. Filed: 2026-01-20 AccNo: 0001475597-26-000001 Size: 3 KB
Read more